LGVN Presents Study Results from CLEAR MIND Phase 2a Clinical Trial of Lomecel-B™ in Mild Alzheimer’s Disease at the Alzheimer’s Association International Conference®
Upvotes: 7
Favorite this post:
Mark as read:
Your rating:
Add this post to a custom list